Use of trilostane for the treatment of pituitary-dependent hyperadrenocorticism in a cat

Skelly, B.J., Petrus, D.J. and Nicholls, P.K. (2003) Use of trilostane for the treatment of pituitary-dependent hyperadrenocorticism in a cat. Journal of Small Animal Practice, 44 (6). pp. 269-272.

PDF - Authors' Version Download (79kB)

Abstract

Hyperadrenocorticism occurs much less frequently in cats than in dogs and, at present, is more difficult to manage successfully. This report documents the use of the steroid synthesis inhibitor trilostane for the treatment of hyperadrenocorticism in a domestic shorthaired cat with pituitary-dependent disease. Although trilostane was able to alleviate the severity of the clinical signs and was well tolerated, the cat subsequently died of renal failure secondary to a fungal infection of the urinary tract.